There was a trend toward a higher percentage of NKp44+ ILC3s in the ST of patients with SpA (median 37.5% [IQR 5.6–64.6%]) compared to the ST of patients with RA (median 3.5% [IQR 0.8–25.6%]); however, this difference did not reach statistical significance ( P = 0.13).
← all excerpts
Expansion of Interleukin-22- and Granulocyte-Macrophage Colony-Stimulating Factor-Expressing, but Not Interleukin-17A-Expressing, Group 3 Innate Lymphoid Cells in the Inflamed Joints of Patients With Spondyloarthritis.
1
0.1300
0.1300